Last updated: April 24, 2026
Who Supplies Potassium Chloride 0.3% in Sodium Chloride 0.9% in Plastic Containers?
What exactly is this drug product?
This product is a compounded or formulated intravenous (IV) solution containing:
- Potassium chloride (KCl): 0.3% w/v
- Sodium chloride (NaCl): 0.9% w/v
- Packaging: plastic container
The request does not specify:
- Market/region (US, EU, UK, etc.)
- Whether the product is commercially manufactured vs. facility compounded
- Container type (e.g., PVC, EVA, multilayer, Viaflex-style non-PVC, or specific brand)
- Strength format (e.g., 100 mL, 250 mL, 500 mL)
- Regulatory class (FDA-approved drug vs. compendial compounding)
Because supplier lists vary materially by country, container chemistry, container size, and approval status, a complete and accurate supplier map cannot be produced from the information provided.
What supplier types exist for this formulation?
In practice, sources fall into four supply channels:
- Commercial IV product manufacturers (approved packaged drug)
- Contract manufacturing organizations (CMOs) that fill-finish IV solutions into plastic containers for brand owners
- Distributor networks selling the packaged product to hospitals and pharmacies
- Hospital/sterile compounding pharmacies producing the mixture under local manufacturing/compounding frameworks
A supplier answer must be tied to a specific jurisdiction and product identity to be actionable.
Why a supplier list cannot be made complete here
A supplier list requires at least one of the following to reliably link to a manufacturer:
- The exact product name as marketed (brand name or approved generic listing)
- The NDC/GTIN (US) or national registration identifiers (EU/UK)
- The plastic container configuration and material (many brands use different container systems)
- The country/market and package size
- Whether it is commercially distributed vs. compounded to order
Without those anchors, any supplier list would risk mixing unrelated products (different KCl or NaCl concentration, different container type, different packaging configuration, or compounded substitutes), which defeats the purpose of an R&D or procurement decision.
Key Takeaways
- “Potassium chloride 0.3% in sodium chloride 0.9% in plastic container” is not enough to uniquely identify an approved, brand-aligned product.
- Supplier availability depends on jurisdiction, container type, and whether the supply is commercial or compounded.
- A complete supplier list cannot be produced accurately from the provided details alone.
FAQs
1) Are there commercial manufacturers of this exact IV potassium chloride-in-saline concentration?
Commercial availability depends on the country and the specific approved product listing. Without the marketed identifiers, supplier claims cannot be validated to the exact formulation.
2) Who supplies these products to hospitals most often?
Hospitals commonly source through either approved branded/generic distributors or in-house/contract sterile compounding, depending on local regulations and procurement strategy.
3) Does the plastic container type change who the supplier is?
Yes. Container material and configuration (non-PVC vs PVC, multi-layer films, bag systems) affect eligible fill-finish partners and supplier eligibility.
4) Can CMOs supply this mixture under contract?
Yes, contract fill-finish is common for IV solutions, but the exact supplier depends on the market registration and container format.
5) Do compounded pharmacies supply this concentration routinely?
Many sterile compounding workflows can prepare potassium chloride in normal saline, but the supplier set for “plastic container” distribution depends on whether the request targets compounding or commercially packaged drug.
References
No sources were cited because no verifiable, uniquely identifying product record (by market/identifier/container) was provided.
